Shares of Nanalysis Scientific Corp. (CVE:NSCI – Get Free Report) fell 19.6% during trading on Saturday . The company traded as low as C$0.18 and last traded at C$0.19. 802,183 shares traded hands during trading, an increase of 866% from the average session volume of 83,002 shares. The stock had previously closed at C$0.23.
Nanalysis Scientific Stock Down 19.6%
The company has a debt-to-equity ratio of 71.72, a current ratio of 1.42 and a quick ratio of 1.11. The business’s 50 day simple moving average is C$0.24 and its 200 day simple moving average is C$0.27. The company has a market capitalization of C$20.95 million, a PE ratio of -1.68 and a beta of -0.75.
Nanalysis Scientific Company Profile
Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies.
Featured Stories
- Five stocks we like better than Nanalysis Scientific
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Auto Tariffs Are Coming Down: 3 Stocks to Benefit Soon
- The 3 Best Retail Stocks to Shop for in August
- Tencent Music Stock Outshines Spotify as China’s Music Giant
- 3 Stocks to Consider Buying in October
- DICKS’s Sporting Goods Stock Dropped After Earnings—Is It a Buy?
Receive News & Ratings for Nanalysis Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanalysis Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
